It can also increase the thymus index, spleen index, IL‐2 and TNF‐α levels, CD3 + T and CD4 + T‐cell percentages, and CD4 + T/CD8 + T values in liver cancer model mice, effectively reducing the immunosuppressive effect of cisplatin (Wang et al. 2018). This evidence concerns the gene CD4 and liver cancer.